Pfizer Asks FDA To Authorize COVID Vaccine For Kids Under 5Pfizer has asked the FDA to authorize extra-low doses of its COVID-19 vaccine for children under 5.
FDA Allows Pfizer Booster Shots For Kids Ages 12-To-15The Food and Drug Administration is now allowing Pfizer booster shots for kids as young as 12. The next step will be CDC approval.
FDA Expected To Allow Pfizer Booster Shots For Kids Ages 12-To-15 SoonThe FDA is reportedly expected to broaden eligibility for Pfizer COVID-19 vaccine boosters to kids ages 12 to 15 in the coming days.
FDA Authorizes First Pill To Treat COVID-19This is the first antiviral Covid-19 pill authorized for ill people to take at home, before they get sick enough to be hospitalized.
Pfizer Says COVID Pill Cuts Risk Of Hospitalization Or Death By 89% In High-Risk PatientsPfizer said the pill cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms.
Massachusetts Vaccine Numbers Show Millions Opting Out Of Third ShotPfizer announced Wednesday that a third dose of its vaccine will likely protect people from the Omicron variant.
FDA Authorizes Moderna, Pfizer COVID Booster Shots For All AdultsThe FDA on Friday authorized Moderna and Pfizer's COVID vaccine booster shots for all adults 18 and older.
COVID Booster Shots Now Available For Anyone 18 Or Older In MassachusettsMassachusetts is opening up COVID booster shots to any fully vaccinated resident age 18 or older, effective immediately.
Pfizer COVID Booster Shot Could Be Available To All Adults By End Of WeekThe Pfizer COVID booster shot could be available to all adults by the end of this week.
Pfizer Expected To Seek Authorization For COVID-19 Vaccine Booster For People 18 And OlderPfizer is expected to seek FDA emergency use authorization for a Covid-19 vaccine booster shot for people 18 and older, making them available to all adults.
Pfizer Says Its Experimental COVID-19 Pill Reduces Risk Of Hospitalization, DeathPfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients.